Interviews of leaders and innovators in pharmaceutical marketing.
A conversation with Adriane Fugh-Berman, MD, Associate professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses ghostwriting, celebrities, symptom quizzes, and numbers to convince men and physicians that 'low testosterone' (Low T) is a medical condition that should be treated.
A discussion with Darshan Kulkarni, Principal Attorney at the Kulkarni Law Firm, about recent court cases involving pharma's right to speak to physicians about off-label uses of approved drugs.
A conversation with Bill Silberg (Principal at Silberg Consulting), Melissa Davies (Social Media Practice Lead at Return on Focus) Michael Parks (Executive Vice President, Vox Medica, Inc.), and invited ePharma Pioneer Club members about
Guests Lee A. Aase, director of the Mayo Clinic Center for Social Media and Edward Bennett, Director, Web and Communications Technology at University of Maryland Medical Center, discuss the Social Media Health Network and the current Healthcare Employee Social Media Access Project & Survey.
Guest Fabio Gratton, Co-founder, Chief Innovation Officer, Ignite Health, and ePharma Pioneer Club™ member, talks about why so few pharmaceutical companies have leveraged the power of social networks to communicate with consumers/patients and how marketers should think differently about the metrics that constitute success.
How Satisfied are Pharma Marketers With Their Digital Efforts? Across Health’s 2011 Digital Barometer
A conversation with Fonny Schenck, Managing Partner/CEO, and Craig Parnell, Managing Partner North America, Across Health, about the 2011 EMEA digital marketing survey for life sciences.
A conversation with Jeff Baker, President and CEO, Noble, about the new world of physician
PharmaGuy interviews Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, about his new book, PharmaPhobia, and his call to action against the 'Conflict of Interest Movement,' which he claims undermines American medical innovation.
In this Pharma Marketing Talk interview, our guest, William D. Cooney, President and CEO, MedPoint Communications, Inc., will lay out the problems of face-to-face speaker programs in today's regulatory, cost-conscious, and busy work-schedule environment. Cooney will give examples of the many benefits of using technology to deliver and manage speaker programs.